Adagio Medical Holdings (ADGM) Net Income towards Common Stockholders (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Net Income towards Common Stockholders data on file, last reported at -$6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 26.34% year-over-year to -$6.8 million; the trailing twelve-month figure through Mar 2026 stood at -$28.0 million (up 40.29% YoY), and the FY2025 full-year result was -$25.1 million, up 53.34% from the prior year.
• Net Income towards Common Stockholders slipped to -$6.8 million in Q1 2026, from -$4.6 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$4.6 million in Q4 2025 to a low of -$33.0 million in Q2 2024.
• A 4-year average of -$10.1 million and a median of -$8.0 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Peak annual rise in Net Income towards Common Stockholders reached 83.81% in 2025, while the deepest fall reached 137.15% in 2025.
• Tracing ADGM's Net Income towards Common Stockholders over 4 years: stood at -$6.8 million in 2023, then jumped by 30.39% to -$4.8 million in 2024, then increased by 3.11% to -$4.6 million in 2025, then plunged by 47.56% to -$6.8 million in 2026.
• Business Quant data shows ADGM's Net Income towards Common Stockholders at -$6.8 million in Q1 2026, -$4.6 million in Q4 2025, and -$11.3 million in Q3 2025.